TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Faster FDA Approvals of New Drugs Would Lead to Lower Prices, Says Premier CEO
Play
LATEST NEWS

As the FDA Takes Center Stage During COVID, Big Changes Could Be Ahead

Jerome-Powell
INVESTING

Jim Cramer: What History Tells Us About Bond-Rate Scares Like This

Chinese health care firms draw strong IPO investors' demand in Hong Kong. Photo: Shutterstock
LATEST NEWS

Quickly Vaccinating Hong Kong May Be a Long Shot

J&J Ordered to Pay $572 Million in Oklahoma Opioid Case
INVESTING

Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA

Stocks Open Higher on Positive Earnings from J&J, Coca-Cola
INVESTING

Johnson & Johnson One-Shot Vaccine Wins Advisory Panel OK

No More Tears for Johnson & Johnson?
INVESTING

J&J Vaccine May Be Near OK, With Shots to Follow Soon After

Moderna Lead
INVESTING

Moderna Extends Gains as Jim Cramer Talks About Potential Cancer Vaccine

PRESS RELEASES

European Medicines Agency Accepts Pfizer's Marketing Authorization Application For Its Investigational 20-valent Pneumococcal Conjugate Vaccine For Adults 18 Years Of Age Or Older

PRESS RELEASES

EMA Accepts Marketing Application For Somatrogon To Treat Pediatric Patients With Growth Hormone Deficiency

Moderna Lead
Video

Moderna Says Trials for COVID Variant Boost Shot Have Begun

  • Feb 25, 2021 11:16 AM EST
Moderna Lead
INVESTING

Moderna Fourth-Quarter Sales Boosted by COVID Vaccine Rollout

PRESS RELEASES

Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants

PRESS RELEASES

Pfizer And BioNTech Initiate A Study As Part Of Broad Development Plan To Evaluate COVID-19 Booster And New Vaccine Variants

New York Stock Exchange Traders Lead
MARKETS

Nvidia, GameStop, AMC, Salesforce, Pfizer - 5 Things You Must Know Thursday

No More Tears for Johnson & Johnson?
INVESTING

Johnson & Johnson COVID Vaccine Gets FDA Support Before Emergency Use Hearing

PRESS RELEASES

Seven Bridges Selected By Pfizer To Support Data Management Solution For Single-Cell RNA Sequencing Data

PRESS RELEASES

U.S. FDA Accepts For Priority Review Pfizer's Application For TicoVac™ (Tick-borne Encephalitis Vaccine)

Johnson & Johnson's Profits Exceeds Analysts' Expectations
INVESTING

Johnson & Johnson Will Deliver 20 Million Vaccine Doses to the U.S. By End of March

Wall Street NYSE Lead
MARKETS

Stocks End Mixed, Nasdaq Sinks as Higher Yields Weigh on Tech

Chinese Cancer Drug Developer Akeso Banks On Pharma Tie-up In Race With Rivals Amid Record-setting Hong Kong IPO
INVESTING

Viatris Slumps as JPMorgan Comments on Weak EBITDA Forecast

PRESS RELEASES

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet
INVESTING

GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials

Lufax is set to make the biggest splash on the NYSE by a Chinese company since e-commerce giant Alibaba's IPO in 2014. Photo: Reuters
INVESTING

Dow Futures Slide on Inflation Concerns, Boeing 777 Suspension

Australia, South Korea, Japan Lead Asia-Pacific Rally On Rising Hopes Lockdowns May Work Against The Coronavirus
LATEST NEWS

Giving Pfizer a Shot: Virologist Gives His Take on the Jab in Japan

The government has already secured millions of doses of the Pfizer-BioNtech Covid-19 vaccine. Photo: AFP
LATEST NEWS

COVID on Track to Kill a Half Million Americans